Ironwood Pharmaceuticals (IRWD) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.31
- Estimate
- $0.28
- Surprise
- +12.7%
- Revenue (period 2026-06-30)
- $113.0M
- Score at report (before → after)
- 7.3 → 7.0/10
Revenue source: xbrl.
How the report landed
Ironwood Pharmaceuticals (IRWD) beat the $0.28 estimate with diluted EPS of $0.31 — a large 12.7% upside surprise. TrendMatrix's engine moved from Buy (Wait) (7.3/10) to Strong Buy at 7.0/10 after the report — the engine's score fell despite the beat.
Where TrendMatrix's rating stands now
TrendMatrix currently rates IRWD Buy (Wait) at 7.5/10.
2 of the last 4 quarters beat the estimate; this quarter's +12.7% surprise compares with a -26.2% four-quarter average. Next scheduled report: 2026-11-09.
What supports the rating
- V7 flight-to-quality bonus: +0.5 (Q=8.9 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Elevated risk factors
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $4.14
- Entry target
- $4.05
- Price target
- $5.18
- Stop
- $3.73
- Upside to target
- +25.1%
- Reward-to-risk
- 3.1:1
The stock trades at 5.3× trailing but 2.7× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-09-17 — shown for context, not personalized investment advice.
IRWD at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Drug Manufacturers - Specialty & Generic
- Market cap
- $670.9M
- P/E (fwd)
- 2.7
- P/E (ttm)
- 5.3
- 52-week range
- $1.26–$5.78
- Off 52-week high
- 28.4%
- RSI (14)
- 45
- Volume vs avg
- 0.90×
- Score today
- 7.5/10